RESEARCH · TRANSPARENCY
2026 Fulvic, Humic, and Shilajit Product Transparency Report
A consumer and publisher checklist for evaluating disclosure quality — labels, testing, source, extraction, separation, and limitations — not a sales ranking.
Conflict of interest (read first): This report is published by Pure Path Northwest LLC, a company that sells fulvic acid, humic acid, and related products. Rows describing Pure Path reflect the company’s stated policies and product architecture. Category-pattern rows are educational composites, not lab certificates for named competitors. Nothing here is medical advice. Dietary supplements are not intended to diagnose, treat, cure, or prevent any disease.
Contents
- Purpose and non-goals
- Methodology
- Transparency dimensions
- Disclosure matrix
- How to read a COA
- Limitations and exclusions
- Update policy
- How to cite this report
1. Purpose and non-goals
Shoppers and journalists evaluating fulvic acid, humic acid, and shilajit products face inconsistent labels, opaque sourcing, and marketing language that outruns public evidence. This report exists to make disclosure habits comparable.
Goals
- Define a repeatable checklist any reader can apply to a product page or seller packet.
- Show how Pure Path documents its own products against that checklist.
- Separate process and testing transparency from disease or performance guarantees.
- Point to the claims substantiation sheet for wording that should be qualified or retired before outreach.
Non-goals
- Not a clinical trial of efficacy.
- Not a secret-shop lab retest of every Amazon SKU.
- Not a “best supplement of 2026” listicle.
- Not permission to copy unverified absorption multiples into headlines.
2. Methodology
Sample frame (v1.0): Pure Path finished goods (fulvic powder, humic powder, Get PPNW starter architecture) plus category-pattern rows representing common blended liquids, shilajit resins, and broad daily powders. Pattern rows encode frequent disclosure gaps observed across the category; they are not adjudications of a single competitor’s current lot.
Evidence types accepted
- On-page label and PDP statements
- Stated QC policy (third-party metals/potency)
- Supply-chain geographic disclosure
- Extraction-method disclosure
- Whether fulvic and humic are sold/timed separately
- Public or on-request Certificate of Analysis (COA)
Evidence types not claimed in v1.0
- Blind multi-brand ICP-MS retesting paid by Pure Path for this edition
- Human RCTs on Pure Path SKUs for bioavailability multiples
- Medical detoxification outcomes
Author: Danny Albert, Founder — dannyalbert.com. Engineering background informs the “receipts first” framing; it does not replace independent laboratory science.
3. Transparency dimensions
Every product can be scored qualitatively on these axes. Prefer primary documents over slogans.
- Label clarity — Does the label state what fraction you are buying (fulvic vs humic vs crude resin vs blend) and the intended role?
- COA published or obtainable — Is there a lot-matched Certificate of Analysis?
- Heavy-metals panel — Are Pb, Cd, As, Hg (and method) addressed?
- Source disclosure — Deposit geography and chain-of-custody language?
- Extraction disclosure — Cold/aqueous vs heat/chemical; solvents; time/temp if claimed?
- Separation — Are fulvic and humic separated for distinct use, or inseparably blended?
- Price per serving transparency — Can a reader compute cost per labeled serving of named material?
- Testing date & lab identity — Is the COA recent and attributable?
- Claims hygiene — Are absorption multiples and medical outcomes absent or tightly cited?
4. Disclosure matrix (v1.0)
Scroll horizontally on mobile. Cells describe disclosure status and architecture, not clinical superiority.
| Product / pattern | Label clarity | COA | Heavy metals | Source | Extraction | Fulvic/humic separated | Price / serving note | Testing date note | Notes |
|---|---|---|---|---|---|---|---|---|---|
| Pure Path Northwest — Fulvic Acid Powder Separated fulvic powder |
Role labeled as delivery/transport molecule; SKU-specific | Policy: lot COA on request (public file library pending upload) | Stated third-party heavy metals + potency per lot | Domestic Utah humate — chain-of-custody claim | Cold-extraction process standard disclosed | Yes — separate SKU from humic | $49 jar (see label serving); compute $/serving from current label | Lot-matched; publish date on COA when released | Primary brand authority property: purepathnorthwest.com |
| Pure Path Northwest — Humic Acid Powder Separated humic powder |
Binding/escort positioning disclosed on PDP | Policy: lot COA on request | Stated third-party heavy metals + potency per lot | Same domestic source family claim | Cold-extraction standard disclosed | Yes — separate SKU from fulvic | $49 jar; evening binding protocols common | Lot-matched when COA issued | Designed to be timed apart from fulvic in dual protocols |
| Get PPNW — 10-Day Protocol Starter dual protocol kit |
AM fulvic / PM humic sequence explained on getppnw.com | Inherited from Pure Path lot policy for enclosed materials | Same parent QC policy | Points to Pure Path sourcing education | Points to cold-extraction explainers | Yes — sequenced, not a single blended mystery powder | $12.99 entry kit (promotional starter economics) | Kit lots follow parent COA policy | Conversion entry — not a clinical trial kit |
| Typical blended “fulvic + humic” liquid (category pattern) Blended liquid drops |
Often generic “humic/fulvic complex” without ratios | Frequently absent or not lot-matched on page | Inconsistent public disclosure | Often vague (country only or undisclosed) | Often undisclosed or “proprietary” | No — blended | Wide range; active grams often unclear | Unknown without seller docs | Pattern row for checklist training — not a named brand attack |
| Typical shilajit resin SKU (category pattern) Crude resin |
May state “purified” without method detail | Variable; authenticity + metals panels not always public | Category risk — demand panel | Region claims common; audit trail varies | Processing often opaque | No — complex resin matrix | Varies widely by purity claims | Require recent COA | See /vs/shilajit for educational comparison framing |
| Typical multi-ingredient daily green / ag1-style powder (category pattern) Broad stack powder |
Long ingredient lists; transport layer rarely specified | Brand-dependent | Brand-dependent | Brand-dependent | N/A for fulvic specifically unless listed | Usually N/A | High $/day common | Brand-dependent | Included so buyers compare disclosure habits across categories — see /vs/ag1 |
5. How to read a COA (practical)
- Match the lot. COA lot/batch IDs should match the bottle or pouch in hand.
- Read units. ppm vs ppb mistakes flip risk interpretation.
- Method matters. ICP-MS / ICP-OES and prep method should be named.
- Potency ≠ purity story alone. “Fulvic content” methods differ; ask what assay was used.
- Microbial panels matter for powders stored in real kitchens, not just metals.
- Absence of a public PDF is not proof of safety or of danger — it is a transparency gap. Ask.
Press / wholesale: Request lot-matched COAs via [email protected] or the Media & Press Kit. A public downloadable COA library will be linked here as files are cleared for open posting.
6. Limitations and exclusions
- Company-authored. Treat Pure Path rows as first-party disclosure, then verify.
- No universal lab bake-off in v1.0. Independent multi-brand retesting is a future edition goal if budget and chain-of-custody allow.
- Category-pattern rows compress common failure modes; individual brands may exceed or lag the pattern.
- Bioavailability multiples (e.g., 4–12×) are not validated as Pure Path clinical endpoints in this report — see the claims sheet.
- Occupational exposure pages (welders, mechanics) are educational context, not OSHA or medical protocols.
- Shilajit authenticity rates are not stated as a fixed market percentage here without a named audit.
7. Update policy
This page is versioned as a living annual report. Material changes (new COA library links, independent retest data, retired claims) update the “Last updated” stamp and changelog below.
- v1.0 — 2026-03-29: Initial public methodology, disclosure matrix, COA reader guide, explicit COI and limitations. Paired claims substantiation sheet published.
8. How to cite this report
Albert, D. (2026). 2026 Fulvic, Humic, and Shilajit Product Transparency Report. Pure Path Northwest. https://purepathnorthwest.com/research/transparency-report-2026
For interviews on testing disclosure, extraction, or founder background: Media Kit · About Danny · dannyalbert.com